Literature DB >> 1442684

CT-guided needle biopsy of the pancreas: a retrospective analysis of diagnostic accuracy.

J Rodriguez1, C Kasberg, M Nipper, J Schoolar, M W Riggs, W P Dyck.   

Abstract

The purpose of this study was to evaluate the accuracy of percutaneous needle biopsy of the pancreas and to compare its sensitivity with that of simple computerized tomographic (CT) prediction of malignancy. The records of 41 patients who underwent CT-guided percutaneous needle biopsies of the pancreas during a 4-yr period were reviewed retrospectively. Pre-biopsy CT scans were evaluated independently by two experienced radiologists in a blinded fashion. Needle biopsy yielded a correct diagnosis of cancer (sensitivity) in only 45% of patients ultimately found to have a malignancy, whereas the radiologic interpretation alone correctly predicted cancer in 76% of such patients. The negative predictive value of needle biopsy was no better (43%) than the radiologist's CT interpretation alone. Our findings confirm previous observations that percutaneous needle biopsy is an insensitive method of diagnosing pancreatic cancer. In our experience, needle biopsy proved less accurate than expert radiologic interpretation of CT scans alone.

Entities:  

Mesh:

Year:  1992        PMID: 1442684

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

Review 1.  The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis.

Authors:  S R Bramhall
Journal:  Int J Pancreatol       Date:  1998-04

Review 2.  Differentiating pancreatic cancer from pseudotumorous chronic pancreatitis.

Authors:  Tony E Yusuf; Manoop S Bhutani
Journal:  Curr Gastroenterol Rep       Date:  2002-04

3.  Diagnostic potency of EUS-guided FNA for the evaluation of pancreatic mass lesions.

Authors:  Amir Houshang Mohammad Alizadeh; Shabnam Shahrokh; Mohammad Hadizadeh; Maryam Padashi; Mohammad Reza Zali
Journal:  Endosc Ultrasound       Date:  2016 Jan-Feb       Impact factor: 5.628

Review 4.  Diagnostic dilemma in pancreatic lymphoma. Case report and review.

Authors:  E Cario; M Rünzi; K Metz; P Layer; H Goebell
Journal:  Int J Pancreatol       Date:  1997-08

5.  Papanicolaou society of cytopathology system for reporting pancreaticobiliary cytology: Risk stratification and cytology scope - 2.5-year study.

Authors:  Abeer M Ilyas; Mamta Bohra; Nilam M More; Leena P Naik
Journal:  Cytojournal       Date:  2022-05-11       Impact factor: 2.345

6.  Ultrasound-guided percutaneous pancreatic tumor biopsy in pancreatic cancer: a comparison with metastatic liver tumor biopsy, including sensitivity, specificity, and complications.

Authors:  Junichi Matsubara; Takuji Okusaka; Chigusa Morizane; Masafumi Ikeda; Hideki Ueno
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

7.  Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration.

Authors:  Jose-Celso Ardengh; Cesar-Vivian Lopes; Luiz-Felipe Pereira de Lima; Juliano-Rodrigues de Oliveira; Filadelfio Venco; Giulio-Cesare Santo; Jose-Luiz-Pimenta Modena
Journal:  World J Gastroenterol       Date:  2007-06-14       Impact factor: 5.742

8.  Rectal cancer staging: Correlation between the evaluation with radial echoendoscope and rigid linear probe.

Authors:  Rogério Colaiácovo; Maurício Saab Assef; Ricardo Leite Ganc; Augusto Pincke Cruz Carbonari; Flávio Amaro Oliveira Bitar Silva; Fang Chia Bin; Lúcio Giovanni Baptista Rossini
Journal:  Endosc Ultrasound       Date:  2014-07       Impact factor: 5.628

Review 9.  Assessment of pancreatic neoplasms: review of biopsy techniques.

Authors:  Steven B Goldin; Michael W Bradner; Emmanuel E Zervos; Alexander S Rosemurgy
Journal:  J Gastrointest Surg       Date:  2007-06       Impact factor: 3.267

10.  Endoscopic ultrasound-guided fine-needle aspiration diagnosis of secondary tumors involving the pancreas: An institution's experience.

Authors:  Almed K Alomari; Berrin Ustun; Harry R Aslanian; Xinquan Ge; David Chhieng; Guoping Cai
Journal:  Cytojournal       Date:  2016-01-28       Impact factor: 2.091

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.